UMU logo

News

New EU course webportal for biomedical postgraduate courses: www.on-course.eu

on-course skärm_250A new EU course webportal is available now!

On-course claims to be "the most comprehensive biomedical and medicines research and development postgraduate course portal in Europe".
on-course® is powered by EMTRAIN, the European Medicines Research Training Network. The EMTRAIN project is funded by the Innovative Medicines Initiative (IMI) Joint Undertaking, a large-scale public-private partnership between the European Union and the pharmaceutical industry association EFPIA.
From Umeå university and UCMR/MIMS the Laboratories for Chemical Biology Umeå (LCBU) at the department of chemistry are our EMTRAIN partners.

Find courses and more information available on

play www.on-course.eu! 

Seminar by John Overington webcasted from FIMM to Umeå


EMBL Partnership for Molecular Medicine (FIMM - MIMS - NCMM) joint Special Seminar at the Biomedicum in Helsinki.
Video transfer of the talk to Umeå and Oslo simultanously.

Speaker:

John Overington
EMBL Outstation - Hinxton,
European Bioinformatics Institute, Cambridge, UK

Title: 
A data mining synthesis approach to the discovery of impersonalised, robust and safe therapies

Read more: Seminar by John Overington webcasted from FIMM to Umeå

Niklas Arnberg receives 1 million SEK from Torsten Söderberg's Foundation

arnberg niklas thumbNiklas Arnberg, group leader at MIMS and professor at the Departement of Clinical Microbiology, is one of three Umeå University researchers who received funds from the Torsten Söderberg Foundation.
Niklas is funded with one million SEK for his research project "virus receptors: their role for tropism, therapy and targeting".

Read the press release from Umeå University (in Swedish)
More about the Torsten Söderberg foundation (in Swedish)

The project description (in Swedish)

Role of NADPH Oxidase versus Neutrophil Proteases in Antimicrobial Host Defense - Publication in PLoS ONE by Constantin Urban and colleagues

Neutrophil proteases but not NADPH oxidase are dispensable in immune defence against Aspergillus fumigatius  and Burkholderia cepacia. This work identified individual contributions of neutrophil defences against microbial pathogens that are common in Chronic Granulomatous Disease (CGD) patients and thus can guide to new therapeutic approaches.

Original Publication:
Vethanayagam RR, Almyroudis NG, Grimm MJ, Lewandowski DC, Pham CTN, et al. (2011) Role of NADPH Oxidase versus Neutrophil Proteases in Antimicrobial Host Defense. PLoS ONE 6(12): e28149. doi:10.1371/journal.pone.0028149

Seven MIMS group leaders funded by the Swedish Research Council

Seven MIMS group leaders funded with 20.4 SEK by the Swedish Research Council (VR).
Emmanuelle Charpentier:  4. 2 million SEK  for  2012-2015 
Nelson Gekara: 2.7 million SEK  for 2012-2014
Constantin Urban: 2.1 million SEK for 2012-2014
Anna Överby Wernstedt: 3.0 million SEK for 2012-2014
Thomas Borén: 3.45 million SEK for 2012-2014
Åke Forsberg: 1.5  million SEK for 2012-2014
Hans Wolf-Watz: 3.45 million SEK for  2012-2014

Press release from Swedish Research Council  on funding in Medicine and health
Press release from Swedish Research Council on funding in Natural and Technical Sciences

Kraftfull substans för nytt läkemedel mot smittsam ögoninfektion

ME0322_PM_AngewChemieJune2011Ny salva eller droppar mot en smittsam och allvarlig ögoninfektion kan nu utvecklas tack vare kreativ forskning i Umeå. Det verksamma ämnet är framtaget av forskare vid Umeå Centre for Microbial Research och Laboratoriet för molekylär infektionsmedicin.

Read more: Kraftfull substans för nytt läkemedel mot smittsam ögoninfektion

Roland Benz honorary doctor at Umeå University

Benz_RolandRoland Benz, member of the Rudolf Virchow Center, University of Würzburg, Germany and Wisdom-Professor in Biotechnology at Jacobs University in Bremen, Germany is one of this year's two doctors who will honoured by the faculty of medicine at Umeå University. Roland Benz has had long time fruitful collaborations with several research groups at the department of Molecular Biology that now are members of UCMR and MIMS. He is an expert on the biophysics, biochemistry and molecular biology of membrane permeability and the mechanisms of transport through membranes. His research includes studies of general diffusion pores and of specific porins in the outer membrane of different Gram-negative bacteria, the processes involved in toxin transport across artificial lipid bilayer membranes, as well as the membrane permeability of cell organelles and import of toxins through lipid bilayer membranes in the target cells.

During several years as Professor for Biotechnology at Theodor-Boveri-Institute (Biocenter) of the University of Würzburg, Roland Benz also coordinated student exchanges in the Erasmus program at Würzburg University and mediated many contacts that brought students to Umeå.
playPress release of Umeå University (in Swedish only)
play
 Press release at Jacobs University, Bremen, Tyskland
playWebpage of Roland Benz at Rudolf Virchow Center, Würzburg
playWepage Roland Benz research at Jacobs University, Bremen

Eric K. Fernström's Prize to Emmanuelle Charpentier

Emmanuelle_Charpentier_web2The prize committee at the Faculty of Medicine, Umeå University, decided to award Emmanuelle Charpentier with Umeå University's Eric K Fernström prize 2011 for young and promising scientists. The prize amount is 100.000 Swedish Krona and Emmanuelle will receive the prize at a ceremony to be held at Lund University on November 2nd, 2011.
According to the founder of the prize, the shipowner Eric K.Fernström, the Fernström foundation awards every year six young researchers at Sweden's six university medical faculties .

Press release, Faculty of Medicine, Umeå University (in Swedish only)


Emmanuelle Charpentier's research group

Eric K. Fernström's foundation





footer all slides 2014-02-06


Copyright © 2019 by The Laboratory for Molecular Infection Medicine Sweden (MIMS). All rights reserved.